113 related articles for article (PubMed ID: 10705875)
21. The natural history of macroprolactinaemia.
Hattori N; Adachi T; Ishihara T; Shimatsu A
Eur J Endocrinol; 2012 Apr; 166(4):625-9. PubMed ID: 22247016
[TBL] [Abstract][Full Text] [Related]
22. Effects of radical mastectomy on prolactin blood levels in patients with breast cancer.
Barni S; Lissoni P; Paolorossi F; Crispino S; Rovelli F; Ferri L; Sormani A; D'Alonso U; Bugatti A; Nociti V
Eur J Cancer Clin Oncol; 1987 Aug; 23(8):1141-5. PubMed ID: 3653210
[TBL] [Abstract][Full Text] [Related]
23. Application of new homologous in vitro bioassays for human lactogens to assess the actual bioactivity of human prolactin isoforms in hyperprolactinaemic patients.
Leaños-Miranda A; Cárdenas-Mondragón G; Rivera-Leaños R; Ulloa-Aguirre A; Goffin V
Clin Endocrinol (Oxf); 2006 Aug; 65(2):146-53. PubMed ID: 16886952
[TBL] [Abstract][Full Text] [Related]
24. Paradoxical stimulation of prolactin secretion by L-dopa in metastatic prostate cancer and its possible role in prostate-cancer-related hyperprolactinemia.
Lissoni P; Mandalà M; Rovelli F; Casu M; Rocco F; Tancini G; Scardino E
Eur Urol; 2000 May; 37(5):569-72. PubMed ID: 10765095
[TBL] [Abstract][Full Text] [Related]
25. Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity.
Leaños-Miranda A; Cárdenas-Mondragón G
Rheumatology (Oxford); 2006 Jan; 45(1):97-101. PubMed ID: 16249247
[TBL] [Abstract][Full Text] [Related]
26. Hyperprolactinemia as a marker of neurotransmitter imbalance in uremic population.
Biasioli S; D'Andrea G; Micieli G; Feriani M; Borin D; Chiaramonte S; Cananzi A; La Greca G
Int J Artif Organs; 1987 Jul; 10(4):245-57. PubMed ID: 2889675
[TBL] [Abstract][Full Text] [Related]
27. Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity.
Jacobi AM; Rohde W; Ventz M; Riemekasten G; Burmester GR; Hiepe F
Lupus; 2001; 10(8):554-61. PubMed ID: 11530997
[TBL] [Abstract][Full Text] [Related]
28. Prolactin secretion in polycystic ovary syndrome (PCOS).
Szosland K; Pawlowicz P; Lewiński A
Neuro Endocrinol Lett; 2015; 36(1):53-8. PubMed ID: 25789595
[TBL] [Abstract][Full Text] [Related]
29. Effects of haloperidol and prolactin secreting tumors on cerebrospinal fluid concentrations of prolactin in the female rat.
Simpkins JW
Life Sci; 1992; 51(4):295-301. PubMed ID: 1625521
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of monochemotherapy with docetaxel (taxotere) in relation to prolactin secretion in heavily pretreated metastatic breast cancer.
Lissoni P; Vaghi M; Ardizzoia A; Fumagalli E; Tancini G; Gardani G; Conti A; Maestroni GJ
Neuro Endocrinol Lett; 2001; 22(1):27-9. PubMed ID: 11335876
[TBL] [Abstract][Full Text] [Related]
31. Altered diurnal rhythm of prolactin in systemic sclerosis.
Hilty C; Brühlmann P; Sprott H; Gay RE; Michel BA; Gay S; Neidhart M
J Rheumatol; 2000 Sep; 27(9):2160-5. PubMed ID: 10990228
[TBL] [Abstract][Full Text] [Related]
32. Node negative breast carcinoma: hyperprolactinemia and/or overexpression of p53 as an independent predictor of poor prognosis compared to newer and established prognosticators.
Patel DD; Bhatavdekar JM; Chikhlikar PR; Ghosh N; Suthar TP; Shah NG; Mehta RH; Balar DB
J Surg Oncol; 1996 Jun; 62(2):86-92. PubMed ID: 8649046
[TBL] [Abstract][Full Text] [Related]
33. Does elevated morning prolactin concentration in children always mean the diagnosis of hyperprolactinemia?
Stawerska R; Smyczyńska J; Hilczer M; Lewiński A
Exp Clin Endocrinol Diabetes; 2015 Jul; 123(7):405-10. PubMed ID: 26069077
[TBL] [Abstract][Full Text] [Related]
34. Some forms of big big prolactin behave as a complex of monomeric prolactin with an immunoglobulin G in patients with macroprolactinemia or prolactinoma.
Cavaco B; Leite V; Santos MA; Arranhado E; Sobrinho LG
J Clin Endocrinol Metab; 1995 Aug; 80(8):2342-6. PubMed ID: 7629227
[TBL] [Abstract][Full Text] [Related]
35. A study of pineal-prolactin interaction: prolactin response to an acute melatonin injection in patients with hyperprolactinemia.
Lissoni P; Mainini E; Mazzi C; Cattaneo G; Barni S
J Endocrinol Invest; 1990 Feb; 13(2):85-9. PubMed ID: 2329263
[TBL] [Abstract][Full Text] [Related]
36. Anti-prolactin autoantibodies in systemic lupus erythematosus patients with associated hyperprolactinemia.
Leaños A; Pascoe D; Fraga A; Blanco-Favela F
Lupus; 1998; 7(6):398-403. PubMed ID: 9736323
[TBL] [Abstract][Full Text] [Related]
37. Long term follow-up of women with surgically treated prolactin-secreting pituitary tumors.
Schlechte JA; Sherman BM; Chapler FK; VanGilder J
J Clin Endocrinol Metab; 1986 Jun; 62(6):1296-301. PubMed ID: 3084539
[TBL] [Abstract][Full Text] [Related]
38. Macroprolactinaemia associated with prolactin adenoma.
Mounier C; Trouillas J; Claustrat B; Duthel R; Estour B
Hum Reprod; 2003 Apr; 18(4):853-7. PubMed ID: 12660284
[TBL] [Abstract][Full Text] [Related]
39. Detection of macroprolactinemia with the polyethylene glycol precipitation test in systemic lupus erythematosus patients with hyperprolactinemia.
Leaños-Miranda A; Pascoe-Lira D; Chávez-Rueda KA; Blanco-Favela F
Lupus; 2001; 10(5):340-5. PubMed ID: 11403264
[TBL] [Abstract][Full Text] [Related]
40. [Hyperprolactinemia: causes, diagnosis, and treatment].
Karasek M; Pawlikowski M; Lewiński A
Endokrynol Pol; 2006; 57(6):656-62. PubMed ID: 17253440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
